Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer
- Autores
- Moro, Lucía Natalia; Viale, Diego Luis; Bastón, Juan Ignacio; Arnold, Victoria; Suvá, Mariana; Wiedenmann, Elisabet; Olguín, Martín; Miriuka, Santiago Gabriel; Vichera, Gabriel Damian
- Año de publicación
- 2020
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The application of new technologies for gene editing in horses may allow the generation of improved sportive individuals.Here, we aimed to knock out the myostatin gene (MSTN), a negative regulator of muscle mass development, using CRISPR/Cas9 and to generate edited embryos for the first time in horses. We nucleofected horse fetal fibroblasts with 1, 2 or 5 µg of 2 different gRNA/Cas9 plasmids targeting the first exon of MSTN. We observed that increasing plasmid concentrations improved mutation efficiency. The average efficiency was 63.6% for gRNA1 (14/22 edited clonal cell lines) and 96.2% for gRNA2 (25/26 edited clonal cell lines). Three clonal cell lines were chosen for embryo generation by somatic cell nuclear transfer: one with a monoallelic edition, one with biallelic heterozygous editions and one with a biallelic homozygous edition, which rendered edited blastocysts in each case. Both MSTN editions and off-targets were analyzed in the embryos. In conclusion, CRISPR/Cas9 proved an efficient method to edit the horse genome in a dose dependent manner with high specificity. Adapting this technology sport advantageous alleles could be generated, and a precision breeding program could be developed.
Fil: Moro, Lucía Natalia. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Viale, Diego Luis. Universidad Nacional de San Martín. Escuela de Ciencia y Tecnología. Centro de Estudios en Salud y Medio Ambiente; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Bastón, Juan Ignacio. Kheiron Sa.; Argentina
Fil: Arnold, Victoria. Kheiron Sa.; Argentina
Fil: Suvá, Mariana. Kheiron Sa.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Wiedenmann, Elisabet. Kheiron Sa.; Argentina
Fil: Olguín, Martín. Kheiron Sa.; Argentina
Fil: Miriuka, Santiago Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina
Fil: Vichera, Gabriel Damian. Kheiron Sa.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina - Materia
-
CRISPR-Cas9
Gene Edition
SCNT
Embryos - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/171450
Ver los metadatos del registro completo
id |
CONICETDig_cb3a4aad4f74f0ab144c844e402fd3c5 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/171450 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transferMoro, Lucía NataliaViale, Diego LuisBastón, Juan IgnacioArnold, VictoriaSuvá, MarianaWiedenmann, ElisabetOlguín, MartínMiriuka, Santiago GabrielVichera, Gabriel DamianCRISPR-Cas9Gene EditionSCNTEmbryoshttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1https://purl.org/becyt/ford/4.4https://purl.org/becyt/ford/4https://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1The application of new technologies for gene editing in horses may allow the generation of improved sportive individuals.Here, we aimed to knock out the myostatin gene (MSTN), a negative regulator of muscle mass development, using CRISPR/Cas9 and to generate edited embryos for the first time in horses. We nucleofected horse fetal fibroblasts with 1, 2 or 5 µg of 2 different gRNA/Cas9 plasmids targeting the first exon of MSTN. We observed that increasing plasmid concentrations improved mutation efficiency. The average efficiency was 63.6% for gRNA1 (14/22 edited clonal cell lines) and 96.2% for gRNA2 (25/26 edited clonal cell lines). Three clonal cell lines were chosen for embryo generation by somatic cell nuclear transfer: one with a monoallelic edition, one with biallelic heterozygous editions and one with a biallelic homozygous edition, which rendered edited blastocysts in each case. Both MSTN editions and off-targets were analyzed in the embryos. In conclusion, CRISPR/Cas9 proved an efficient method to edit the horse genome in a dose dependent manner with high specificity. Adapting this technology sport advantageous alleles could be generated, and a precision breeding program could be developed.Fil: Moro, Lucía Natalia. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Viale, Diego Luis. Universidad Nacional de San Martín. Escuela de Ciencia y Tecnología. Centro de Estudios en Salud y Medio Ambiente; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Bastón, Juan Ignacio. Kheiron Sa.; ArgentinaFil: Arnold, Victoria. Kheiron Sa.; ArgentinaFil: Suvá, Mariana. Kheiron Sa.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Wiedenmann, Elisabet. Kheiron Sa.; ArgentinaFil: Olguín, Martín. Kheiron Sa.; ArgentinaFil: Miriuka, Santiago Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; ArgentinaFil: Vichera, Gabriel Damian. Kheiron Sa.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaNature2020-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/171450Moro, Lucía Natalia; Viale, Diego Luis; Bastón, Juan Ignacio; Arnold, Victoria; Suvá, Mariana; et al.; Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer; Nature; Scientific Reports; 10; 1; 9-2020; 1-152045-2322CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://www.nature.com/articles/s41598-020-72040-4info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-020-72040-4info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:33:23Zoai:ri.conicet.gov.ar:11336/171450instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:33:24.037CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer |
title |
Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer |
spellingShingle |
Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer Moro, Lucía Natalia CRISPR-Cas9 Gene Edition SCNT Embryos |
title_short |
Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer |
title_full |
Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer |
title_fullStr |
Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer |
title_full_unstemmed |
Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer |
title_sort |
Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer |
dc.creator.none.fl_str_mv |
Moro, Lucía Natalia Viale, Diego Luis Bastón, Juan Ignacio Arnold, Victoria Suvá, Mariana Wiedenmann, Elisabet Olguín, Martín Miriuka, Santiago Gabriel Vichera, Gabriel Damian |
author |
Moro, Lucía Natalia |
author_facet |
Moro, Lucía Natalia Viale, Diego Luis Bastón, Juan Ignacio Arnold, Victoria Suvá, Mariana Wiedenmann, Elisabet Olguín, Martín Miriuka, Santiago Gabriel Vichera, Gabriel Damian |
author_role |
author |
author2 |
Viale, Diego Luis Bastón, Juan Ignacio Arnold, Victoria Suvá, Mariana Wiedenmann, Elisabet Olguín, Martín Miriuka, Santiago Gabriel Vichera, Gabriel Damian |
author2_role |
author author author author author author author author |
dc.subject.none.fl_str_mv |
CRISPR-Cas9 Gene Edition SCNT Embryos |
topic |
CRISPR-Cas9 Gene Edition SCNT Embryos |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 https://purl.org/becyt/ford/4.4 https://purl.org/becyt/ford/4 https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
The application of new technologies for gene editing in horses may allow the generation of improved sportive individuals.Here, we aimed to knock out the myostatin gene (MSTN), a negative regulator of muscle mass development, using CRISPR/Cas9 and to generate edited embryos for the first time in horses. We nucleofected horse fetal fibroblasts with 1, 2 or 5 µg of 2 different gRNA/Cas9 plasmids targeting the first exon of MSTN. We observed that increasing plasmid concentrations improved mutation efficiency. The average efficiency was 63.6% for gRNA1 (14/22 edited clonal cell lines) and 96.2% for gRNA2 (25/26 edited clonal cell lines). Three clonal cell lines were chosen for embryo generation by somatic cell nuclear transfer: one with a monoallelic edition, one with biallelic heterozygous editions and one with a biallelic homozygous edition, which rendered edited blastocysts in each case. Both MSTN editions and off-targets were analyzed in the embryos. In conclusion, CRISPR/Cas9 proved an efficient method to edit the horse genome in a dose dependent manner with high specificity. Adapting this technology sport advantageous alleles could be generated, and a precision breeding program could be developed. Fil: Moro, Lucía Natalia. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Viale, Diego Luis. Universidad Nacional de San Martín. Escuela de Ciencia y Tecnología. Centro de Estudios en Salud y Medio Ambiente; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Bastón, Juan Ignacio. Kheiron Sa.; Argentina Fil: Arnold, Victoria. Kheiron Sa.; Argentina Fil: Suvá, Mariana. Kheiron Sa.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Wiedenmann, Elisabet. Kheiron Sa.; Argentina Fil: Olguín, Martín. Kheiron Sa.; Argentina Fil: Miriuka, Santiago Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina Fil: Vichera, Gabriel Damian. Kheiron Sa.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina |
description |
The application of new technologies for gene editing in horses may allow the generation of improved sportive individuals.Here, we aimed to knock out the myostatin gene (MSTN), a negative regulator of muscle mass development, using CRISPR/Cas9 and to generate edited embryos for the first time in horses. We nucleofected horse fetal fibroblasts with 1, 2 or 5 µg of 2 different gRNA/Cas9 plasmids targeting the first exon of MSTN. We observed that increasing plasmid concentrations improved mutation efficiency. The average efficiency was 63.6% for gRNA1 (14/22 edited clonal cell lines) and 96.2% for gRNA2 (25/26 edited clonal cell lines). Three clonal cell lines were chosen for embryo generation by somatic cell nuclear transfer: one with a monoallelic edition, one with biallelic heterozygous editions and one with a biallelic homozygous edition, which rendered edited blastocysts in each case. Both MSTN editions and off-targets were analyzed in the embryos. In conclusion, CRISPR/Cas9 proved an efficient method to edit the horse genome in a dose dependent manner with high specificity. Adapting this technology sport advantageous alleles could be generated, and a precision breeding program could be developed. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-09 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/171450 Moro, Lucía Natalia; Viale, Diego Luis; Bastón, Juan Ignacio; Arnold, Victoria; Suvá, Mariana; et al.; Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer; Nature; Scientific Reports; 10; 1; 9-2020; 1-15 2045-2322 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/171450 |
identifier_str_mv |
Moro, Lucía Natalia; Viale, Diego Luis; Bastón, Juan Ignacio; Arnold, Victoria; Suvá, Mariana; et al.; Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer; Nature; Scientific Reports; 10; 1; 9-2020; 1-15 2045-2322 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://www.nature.com/articles/s41598-020-72040-4 info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-020-72040-4 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Nature |
publisher.none.fl_str_mv |
Nature |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614349129252864 |
score |
13.070432 |